The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 224,131 | 689,550 | SH | SOLE | 689,550 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 32,761 | 2,026,063 | SH | SOLE | 2,026,063 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 33,191 | 1,387,589 | SH | SOLE | 1,387,589 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 19,082 | 1,861,630 | SH | SOLE | 1,861,630 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 117,253 | 1,204,328 | SH | SOLE | 1,204,328 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 32,843 | 156,823 | SH | SOLE | 156,823 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 2,164 | 3,013,793 | SH | SOLE | 3,013,793 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 51,350 | 3,380,506 | SH | SOLE | 3,380,506 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 70,905 | 7,401,321 | SH | SOLE | 7,401,321 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 217,961 | 2,559,733 | SH | SOLE | 2,559,733 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 34,139 | 532,667 | SH | SOLE | 532,667 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 94,098 | 5,239,304 | SH | SOLE | 5,239,304 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 782 | 123,686 | SH | SOLE | 123,686 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 5,355 | 500,913 | SH | SOLE | 500,913 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 42,720 | 6,935,074 | SH | SOLE | 6,935,074 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 19,869 | 314,889 | SH | SOLE | 314,889 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 11,003 | 175,900 | SH | SOLE | 175,900 | 0 | 0 | ||
HISTOGENICS CORP | COM | 43358V109 | 27 | 302,922 | SH | SOLE | 302,922 | 0 | 0 | ||
IDERA PHARMACEUTICALS INC | COM PAR | 45168K405 | 213 | 77,044 | SH | SOLE | 77,044 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 74,008 | 5,186,255 | SH | SOLE | 5,186,255 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 100,415 | 7,653,617 | SH | SOLE | 7,653,617 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 43,902 | 4,685,352 | SH | SOLE | 4,685,352 | 0 | 0 | ||
MELINTA THERAPEUTICS INC | COM | 58549G100 | 40 | 50,689 | SH | SOLE | 50,689 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 20,331 | 1,841,613 | SH | SOLE | 1,841,613 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 11,418 | 1,108,510 | SH | SOLE | 1,108,510 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 23,604 | 1,159,900 | SH | SOLE | 1,159,900 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 9,168 | 3,985,945 | SH | SOLE | 3,985,945 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 81,515 | 850,977 | SH | SOLE | 850,977 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 8,343 | 47,938 | SH | SOLE | 47,938 | 0 | 0 | ||
SOPHIRIS BIO INC | COM NEW | 83578Q209 | 205 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 132,362 | 4,147,988 | SH | SOLE | 4,147,988 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 483 | 1,162,473 | SH | SOLE | 1,162,473 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 177,728 | 1,632,025 | SH | SOLE | 1,632,025 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 108,588 | 4,155,670 | SH | SOLE | 4,155,670 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 75,437 | 2,771,394 | SH | SOLE | 2,771,394 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,076 | 29,500 | SH | SOLE | 29,500 | 0 | 0 |